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(57) ABSTRACT 
Microfluidic devices for cell culturing and methods for using 
the same are disclosed. One device includes a substrate and 
membrane. The substrate includes a reservoir in fluid com-
munication with a passage. A bio-compatible fluid may be 
added to the reservoir and passage. The reservoir is config-
ured to receive and retain at least a portion of a cell mass. The 
membrane acts as a barrier to evaporation of the bio-compat- 
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awarded by the NASA BioScience and Engineering Institute; 
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Department of Agriculture. The Government has certain 
rights to the invention. 
BACKGROUND 
1. Field of the Invention 
The invention relates to microfluidic cell culture devices. 
2. Discussion 
Microfluidic devices allow a user to work with nano- to 
microliter volumes of fluids and are useful for reducing 
reagent consumption, creating physiologic cell culture envi-
ronments that better match the fluid-to-cell-volume ratios in 
vivo, and performing experiments that take advantage of low 
Reynolds number phenomenon such as subcellular treatment 
of cells with multiple laminar streams. Many microfluidic 
systems are made of polydimethylsiloxane (PDMS) because 
of its favorable mechanical properties, optical transparency, 
and bio-compatibility. 
Cell culture is an essential tool in biological science, clini-
cal science, and biotechnology. Microfluidic cell culture 
devices offer the advantages of increased fluid control, 
approximated physiologic culture environments, and 
improved culture efficiency. 
Microfluidic cell culture devices have been developed for 
diverse cell types such as Eukaryotic cells, lung cells, embry-
onic stem cells, and mammalian embryos. 
Most microfluidic cell culture devices separate cell loading 
zones from designated cell culture zones. This separation 
requires additional external forces and elaborate works for the 
cell in the loading zone to be transported to the designated 
culture zone. Also, the transport processes can put stress on 
sensitive cells such as mammalian embryo or embryonic stem 
cells. In addition, once the cells reach the designated culture 
zone, additional design and fabrications are required for cell 
confinement to apply diverse culture conditions with flows. 
SUMMARY 
Embodiments of the invention may take the form of a 
microfluidic cell culture device. The device includes a sub-
strate and a reservoir formed in the substrate having upper and 
lower portions. The upper portion is sized to permit the inser- 
2 
tion and removal of a cell mass from the reservoir. The device 
also includes a passage formed in the substrate and in fluid 
communication with the reservoir. At least one of the lower 
portion of the reservoir and the passage adjacent the lower 
5 portion is sized relative to the cell mass to retain at least a 
portion of the cell mass within the lower portion of the reser-
voir so that the cell mass can be directly removed from the 
lower portion through the upper portion. 
The lower portion of the reservoir may be sized relative to 
l0 the cell mass to retain at least a portion of the cell mass within 
the lower portion of the reservoir so that the cell mass can be 
directly removed from the lower portion through the upper 
portion. 
15 	 The lower portion of the reservoir may have a width less 
than 250 micrometers to retain at least a portion of the cell 
mass within the reservoir. 
The lower portion of the reservoir may have a width, the 
cell mass may be a denuded human zygote, and the width may 
20 be less than 140 micrometers to retain at least a portion of the 
cell mass within the reservoir. 
The lower portion of the reservoir may have a width, the 
cell mass may be a denuded mammalian zygote, and the 
width may be less than 70 micrometers to retain at least a 
25 portion of the cell mass within the reservoir. 
The lower portion of the reservoir may have a width, the 
cell mass may be a clump of mammalian cells, and the width 
may be less than 50 micrometers to retain at least a portion of 
the cell mass within the reservoir. 
30 	 The lower portion of the reservoir may have a width, the 
cell mass may be a single mammalian cell, and the width may 
be less than 5 micrometers to retain at least a portion of the 
cell mass within the reservoir. 
The passage adjacent the lower portion may be sized rela- 
35 tive to the cell mass to retain at least a portion of the cell mass 
within the lower portion of the reservoir so that the cell mass 
can be directly removed from the lower portion through the 
upper portion. 
The passage adjacent the lower portion may have a passage 
40 width and a passage height and at least one of the passage 
height and the passage width may be less than 250 microme-
ters to retain at least a portion of the cell mass within the 
reservoir. 
The pas sage adjacent the lower portion may have a pas sage 
45 width and a passage height, the cell mass may be a denuded 
human zygote, and at least one of the passage height and the 
passage width may be less than 140 micrometers to retain at 
least a portion of the cell mass within the reservoir. 
The passage adjacent the lower portion may have a passage 
50 width and a passage height, the cell mass may be a denuded 
mammalian zygote, and at least one of the passage height and 
the passage width may be less than 70 micrometers to retain 
at least a portion of the cell mass within the reservoir. 
The passage adjacent the lower portion may have a passage 
55 width and a passage height, the cell mass may be a clump of 
mammalian cells, and at least one of the passage height and 
the passage width may be less than 50 micrometers to retain 
at least a portion of the cell mass within the reservoir. 
The passage adjacent the lower portion may have a passage 
60 width and a passage height, the cell mass may be a single 
mammalian cell, and at least one of the passage height and the 
passage width may be less than 5 micrometers to retain at 
least a portion of the cell mass within the reservoir. 
A cross-section of the reservoir may have a polygonal 
65 shape. The reservoir may have a frusta-conical shape. 
An angle defined by opposite surfaces of the reservoir may 
be between 30 degrees and 160 degrees inclusive. 
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The upper portion may have an upper width and the lower 
portion may have a lower width and the upper width may be 
greater than the lower width. 
A surface of the reservoir may taper inwardly from the 
upper portion to the lower portion. 
The passage may be U-shaped. 
The passage may have a volume less than 1 microliter. 
While exemplary embodiments in accordance with the 
invention are illustrated and disclosed, such disclosure should 
not be construed to limit the claims. It is anticipated that 
various modifications and alternative designs may be made 
without departing from the scope of the invention. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is an exploded, perspective view of a microfluidic 
cell culture device in accordance with an embodiment of the 
invention; 
FIG. 2a is a top view of a substrate of the system of FIG. 1; 
FIG. 2b is a side view, and in cross-section, of the substrate 
taken along section line 2b-2b in FIG. 2a; 
FIG. 2c is a bottom view of the substrate of FIG. 2a; 
FIG. 3a is a side view, partially broken-away and in cross-
section, of a membrane of the system of FIG.1 with a pair of 
actuator pins in engagement with a lower surface of the mem-
brane; 
FIG. 3b is a side view, partially broken-away and in cross-
section, of an alternative embodiment of a membrane of the 
system of FIG. 1 with a pair of actuator pins spaced away 
from the lower surface of the membrane; 
FIG. 4a is a side view, partially broken-away and in cross-
section, of an alternative embodiment of the substrate of FIG. 
1 and the membrane of FIG. 3b and illustrating two different 
heights of a biological fluid in a pair of reservoirs formed in 
the substrate; 
FIG. 4b is an enlarged side view, partially broken-away and 
in cross-section, of the substrate and membrane of FIG. 4a 
and illustrating the relative heights of a cell mass and an end 
portion of a passageway; 
FIG. 4c is another enlarged side view, partially broken-
away and in cross-section, of the substrate and membrane of 
FIG. 4a and illustrating the angle of the surface which defines 
a reservoir and the relative widths of a cell mass and a lower 
portion of the reservoir; 
FIG. 5a is an enlarged side view, partially broken-away and 
in cross-section, of an alternative embodiment of a substrate 
and membrane of FIG. 1 and illustrating a cell mass retained 
in a lower portion of the reservoir above the passageway; 
FIG. 5b is another enlarged side view, partially broken-
away and in cross-section, of an alternative embodiment of a 
substrate and membrane of FIG.1 and illustrating a cell mass 
retained in a lower portion of the reservoir below the passage-
way; and 
FIG. 5c is yet another enlarged side view, partially broken-
away and in cross-section, of an alternative embodiment of a 
substrate and membrane of FIG.1 and illustrating a cell mass 
with a width smaller than the width of the lower portion of the 
reservoir. 
DETAILED DESCRIPTION 
FIG.1 is an exploded, perspective view of microfluidic cell 
culture system or device 10. Device 10 includes substrate 12 
configured to receive a cellular mass, e.g., an embryo, as 
explained in detail below, non-rigid membrane 14, locating 
block 16, and pin actuating device 18. 
4 
FIG. 2a is a top view of substrate 12. Substrate 12 includes 
funnel 22, reservoir 24, and overlay reservoir 26. Bottom 
portion 28 of funnel 22 is in fluid communication with reser-
voir 24 via microchannel 30. Microchannel 30 has a volume 
5 less than 1 microliter. Reservoir 24 includes reservoir open-
ings 32 whichprovide openings to microchannel 30 such that 
fluids may travel between funnel 22 and reservoir 24 as 
explained in detail below. 
FIG. 2b is a side view, and in cross-section, of substrate 12 
io taken along section line 2b-2b in FIG. 2a. Aportion of micro-
channel 30 is formed in substrate 12 while another portion of 
microchannel 30 is formed by membrane 14 as described in 
detail below. Microchannel 30, however, may be completely 
formed in substrate 12 or in any other suitable fashion. Micro- 
15 channel 30 may have a square, circular, bell, or any other 
suitably shaped cross-section. Substrate 12 further includes 
hydrophilic surface 34 to promote fluid retention within over-
lay reservoir 26. 
Fluid may move between funnel 22 and reservoir 24 via 
20 localized deformation of membrane 14. Fluid may also move 
between funnel 22 and reservoir 24 under the influence of 
gravity as explained in detail below. 
Substrate 12 may be optically transparent and made from 
such materials as plastic, e.g., PDMS, polymethylmethacry-
25 late, polyurethane, or glass. 
FIG. 2c is a bottom view of substrate 12. Substrate 12 
includes female locators 36 which assist in locating substrate 
12 relative to membrane 14 as explained in detail below. 
Substrate 12 may comprise a thick, e.g., 8 mm, PDMS slab, 
30 fabricated by using soft lithography. The PDMS slab may be 
prepared by casting a prepolymer (Sylgard 184, Dow-Corn-
ing) at a 1:10 curing agent-to-base ratio against positive relief 
features. Relief features may comprise SU-8 (MicroChem, 
Newton, Mass.) and be fabricated on a thin, e.g., 200 µm, 
35 glass wafer by using backside diffused-light photolithogra-
phy. The prepolymer may then cure at 60° C. for 60 minutes, 
and holes may be punched by a sharpened 14-gauge blunt 
needle. 
Substrate 12 may comprise two layers of cured PDMS at a 
4o ratio of 1:10 base to curing agent sealed together irreversibly 
using plasma oxidation (SPI supplies, West Chester, Pa.). 
Funnel 22 and reservoir 24 are formed in the top layer. Micro-
channel 30 is formed in the bottom layer using soft lithogra-
phy. Microchannel 30 faces downward and may be sealed 
45 against membrane 14 as explained in detail below. 
FIG. 3a is a side view, partially broken-away and in cross-
section, of membrane 14 and pins 54 of pin actuating device 
18 (FIG. 1). Membrane 14 includes male locators 38 (FIG. 1) 
configured to be received by female locators 36 of substrate 
50 12 to locate membrane 14 relative to substrate 12. 
Membrane 14 is optically transparent and includes top 
layer 40, upper surface 41, middle layer 42, bottom layer 44, 
and bottom surface 45. Top layer 40 and bottom layer 42 
comprise PDMS. Middle layer 42 comprises parylene. Top 
55 layer 40 and bottom layer 44, alternatively, may comprise any 
suitable non-rigid, bio-compatible polymer such as a non-
rigid plastic, e.g., polyurethane, or a hyrdrogel, e.g., polyvi-
nylalcohol. Middle layer 42, alternatively, may comprise any 
suitable non-rigid polymer such as polyvinylidene chloride or 
60 polyurethane. 
Top layer 40 and bottom layer 44 may have a combined 
thickness of less than 1 mm, e.g., 200 µm. Middle layer 42 
may range in thickness from 2-20 µm, e.g., 2-5 µm. 
Pins 54 of pin actuating device 18 may selectively extend 
65 from the position shown into membrane 14 to locally deform 
membrane 14 such that at least a portion of top layer 40 
extends into microchannel 30 (FIG. 2b). The selective actua- 
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tion of pins 54 may move a fluid in microchannel 30 or 	 Pin actuating device 18 is a Braille-type actuator as 
prevent, or impede, the movement of the fluid in microchan- 	 described in detail below. Pins 54 are actuated with a force of 
nel 30 as explained in detail below. 	 18 g. Pins 54, however, may be actuated with a force ranging 
Middle layer 42 minimizes evaporation of a fluid, e.g., a 	 from approximate 3 g to 300 g. Pins 54 may be actuated, for 
water based fluid, contained within microchannel 30 to pre-  5 example, 10 times per second or once a minute. Pins 54 may 
vent, for example, undesirable shifts in osmolality of the 	 be actuated for a period ranging from minutes to weeks. Any 
fluid. Middle layer 42 is also resistant to the flow of at least 	 suitable tactile device, however, may be used. 
one gas, such as oxygen and carbon dioxide, from microchan- 	 Pins 54 of pin actuating device 18, when actuated, extend 
nel 30 and provides mechanical durability and stability 	 and press upon membrane 14, restricting or closing micro- 
against cracking caused by the selective actuation of pins 54. io channel 30. Pins 54 may be actuated in any suitable fashion 
Fatigue from the actuation of pins 54 does not substantially 	 such that a fluid flows between funnel 22 and reservoir 24 via 
increase middle layer's 42 ability to substantially reduce the 	 microchannel 30. Pins 54 may also be actuated such that the 
rate at which a fluid from microchannel 30 moves through 
	
fluid does not move between funnel 22 and reservoir 24 via 
membrane 14. 	 microchannel 30. 
Membrane 14 includes female locators (not shown) which 15 	 Pin actuating device 18 includes male locators 56. Male 
are used to locate membrane 14 relative to locating block 16 
	
locators 56 are configured to be received by female locators 
as explained in detail below. 	 52 of locating block 16 to align locating block 16 relative to 
Membrane 14 may be prepared by spin-coating PDMS 	 pin actuating device 18. By aligning locators 46, 56, pins 54 
onto a 4" silanized silicon wafer to a thickness of 100 µm, 	 are aligned with pin holes 48. 
curing this layer at 120° C. for 30 minutes, depositing a 2.5 or 20 	 FIG. 4a is side view, partially broken-away and in cross- 
5 µm thick parylene layer, plasma oxidizing the resulting 	 section, of substrate 112 and membrane 114. Reservoir 124 
parylene surface for 90 seconds, spin-coating another 100 µm 	 and funnel 122 are in fluid communication via microchannel 
thick layer of PDMS, and curing for a total thickness of 
	
130. Bio-compatible fluid 158 may be transported between 
approximately 200 µm. 	 reservoir 124 and funnel 122 via localized deformation of 
FIG. 3b is a side view, partially broken-away and in cross- 25 membrane 114 by pin actuating device 118. D is the differ-
section, of an alternative embodiment of membrane 114 and 	 ence in height between bio-compatible fluid 158 in reservoir 
pins 154 of pin actuating device 118 (not shown). Membrane 	 124 and funnel 122. 
114 includes top layer 140, upper surface 141, bottom layer 	 Funnel 122 and reservoir 124 are further in fluid commu- 
142, and lower surface 145. Top layer 140 comprises PDMS 	 nication via upper channel 126. Microchannel 130 has a 
and bottom layer 142 comprises polyvinylidene chloride. Top 3o resistance to fluid flow greater than upper channel 126. Upper 
layer 140, alternatively, may comprise any suitable non-rigid, 	 channel 126 is defined by a hydrophobic surface to, for 
bio-compatible polymer such as a non-rigid plastic, e.g., 	 example, repel bio-compatible fluid 158. 
polyurethane, or a hyrdrogel, e.g., polyvinylalcohol, whereas 	 Immiscible fluid 160, e.g., an oil having a density lower 
bottom layer 142 may comprise any suitable non-rigid poly- 	 than bio-compatible fluid 158, may move between funnel 122 
mer such as polyurethane. 	 35 and reservoir 124 via channel 126. Immiscible fluid 160 
Top layer 140 and bottom layer 142 may have a combined 	 reduces evaporation of bio-compatible fluid 158 and reduces 
thickness of less than 1 mm, e.g., 200 µm. 	 the flow of oxygen and carbon dioxide into and out bio- 
Bottom layer 142 minimizes evaporation of a fluid, e.g., a 	 compatible fluid 158. Gravity will act upon immiscible fluid 
water based fluid, contained within microchannel 30 to pre- 	 160 such that the height of immiscible fluid 160 in funnel 122 
vent, for example, undesirable shifts in osmolality of the 40 will equal the height of immiscible fluid 160 in reservoir 124 
fluid. Bottom layer 142 is also resistant to the flow of at least 	 thereby maintaining the difference in height, D, of bio-com- 
one gas, such as oxygen and carbon dioxide, from microchan- 	 patible fluid 158. 
nel 30 and provides mechanical durability and stability 	 D' is the desired difference in height between bio-compat- 
against cracking caused by the selective actuation of pins 154. 	 ible fluid 158 in funnel 122 and bio-compatible fluid 158 in 
Fatigue from the actuation of pins 154 does not substantially 45 reservoir 124 after pin actuating device 118, for example, has 
increase bottom layer's 142 ability to substantially reduce the 	 been used to move bio-compatible fluid 158 from reservoir 
rate at which a fluid from microchannel 30 moves through 
	
124 to funnel 122. Such a height may provide a desired 
membrane 114. 	 amount of fluid in funnel 122 conducive to cell culturing. As 
Membrane 114 may be prepared by spin-coating freshly 	 bio-compatible fluid 158 is moved from reservoir 124 to 
mixed 1:10 PDMS onto silanized glass slides (Corning Glass 50 funnel 122, immiscible fluid 160 will flow from funnel 122 to 
Works, Corning, N.Y.) to a uniform thickness of either 	 reservoir 124 via channel 126 under the influence of gravity 
approximately 120 µm or 400 µm, curing overnight at 120° 	 such that in the absence of deformation of membrane 114 that 
C., and then adhering polyvinylidene chloride via conformal 	 would cause, for example, bio-compatible fluid 158 to further 
contact with the PDMS. 	 move between funnel 122 and reservoir 124 or prevent bio- 
Referring to FIG. 1, locating block 16 includes pin holes 48 55 compatible fluid 158 from moving between funnel 122 and 
and male locators 50. Pin holes 48 are configured to receive 	 reservoir 124, immiscible fluid 160 will substantially main- 
pins 54 of pin actuating device 18. Male locators 50 are 	 tain the difference in height D' under the influence of gravity 
configured to be received by the female locators of membrane 	 for a desired period of time, e.g., approximately 30 minutes. 
14 to locate locating block 16 relative to membrane 14. In 	 Microchannel 130 and channel 126 thus from a continuous 
particular, by locating block 16 relative to membrane 14, pin 60 fluid path between funnel 122 and reservoir 124. 
holes 48 are aligned with microchannel 30. Locating block 16 
	
Fluid may move between funnel 122 and reservoir 124 in 
includes female locators (not shown) which are used to locate 	 any number of ways. For example, a pump may pump immis- 
locating block 16 relative to pin actuating device 18 as 	 cible fluid 160 from one of funnel 122 and reservoir 124 to the 
explained in detail below. 	 other of funnel 122 and reservoir 124 thereby changing the 
Locating block 16 is rigid and optically transparent and 65 height of bio-compatible fluid 158. 
made from such materials as polystyrene, cyclic olefin 	 Funnel 122 includes upper portion 164 and lower portion 
copolymer, glass, or metal. 	 166. Surface 168 of funnel 122 tapers inwardly from upper 
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portion 164 to lower portion 166. Furthermore, upper portion 
164 has a width greater than lower portion 166. 
The shape of funnel 122 facilities the one-step loading and 
unloading of cells into and out of lower portion 166. A pipette 
holding cells may be inserted into funnel 122 at an angle such 
that a user has a substantially unobstructed view of lower 
portion 166. Likewise, a pipette may be inserted into funnel 
122 to remove cells from lower portion 166 such that a user 
has a substantially unobstructed view of lower portion 166. 
FIG. 4b is an enlarged side view, partially broken-away and 
in cross-section, of funnel 122 and microchannel 130. Lower 
portion 166 of funnel 122 is configured to receive cellular 
mass 170. Cellular mass 170 has a cellular height H and 
microchannel 130 has a channel height h. Cellular mass 170 
may be, for example, a human zygote, a mammalian zygote, 
a clump of mammalian cells, or a single mammalian cell. 
Microchannel 130 is configured such that cellular mass 170 
will not exit lower portion 166 of funnel 122. 
FIG. 4c is another enlarged side view, partially broken-
away and in cross-section, of funnel 122 and microchannel 
130 looking down the length of microchannel 130. Cellular 
mass 170 has a cellular width W and microchannel 130 has a 
channel width w. Cellular mass 170 also has a cellular length 
(not shown). Microchannel 130 may be configured such that 
at least one of the channel height h and the channel width w is 
less than at least one of the cellular height H, the cellular 
width W, and the cellular length L. 
Angle  is defined by opposite surfaces 168 of funnel 122. 
Angle A may range between 30° and 160° inclusive. 
At least one of the channel height h and the channel width 
w may be less than 250 µm or the width of human hair. In the 
case where cellular mass 170 is a denuded human zygote, at 
least one of the channel height h and the channel width w may 
be less than 140 µm. In the case where cellular mass 170 is a 
denuded mammalian zygote, at least one of the channel 
height h and the channel width w may be less than 70 µm. In 
the case where cellular mass 170 is a clump of mammalian 
cells, at least one of the channel height h and the channel 
width w may be less than 50 µm. In the case where cellular 
mass 170 is a single mammalian cell, at least one of the 
channel height h and the channel width w may be less than 5 
µm. 
FIG. 5a is an enlarged side view, partially broken-away and 
in cross-section, of funnel 222 and microchannel 230. Lower 
portion 266 is sized such that a portion of cellular mass 270 is 
confined to lower portion 266. 
Lower portion 266 may have a width less than 250 µm. In 
the case where cellular mass 270 is a denuded human zygote, 
the width may be less than 140 µm. In the case where cellular 
mass 270 is a denuded mammalian zygote, the width may be 
less than 70 µm. In the case where cellular mass 270 is a 
clump of mammalian cells, the width may be less than 50 µm. 
In the case where cellular mass 270 is a single mammalian 
cell, the width may be less than 5 µm. 
FIG. 5b is an enlarged side view, partially broken-away and 
in cross-section, of funnel 322 and microchannel 330. Lower 
portion 366 is sized such that a portion of cellular mass 370 is 
confined to lower portion 366. Additionally, microchannel 
330 is above lower portion 366. 
FIG. 5c is an enlarged side view, partially broken-away and 
in cross-section, of funnel 422 and microchannel 430. Lower 
portion 466 and microchannel 430 are sized such that por-
tions of cellular mass 470 may be in either of lower portion 
466 and the portion of microchannel 430 adjacent lower 
portion 466. 
Embodiments of the invention may take the form of a 
microfluidic device composed of a PDMS slab with bell- 
8 
shaped microfluidic channel features, a culture media reser-
voir, and a funnel shaped well for culture. The media reservoir 
and funnel shaped well are connected with the microfluidic 
channels. The funnel shaped well may have an approach 
5 angle of approximately 60° to facilitate the one-step loading 
and unloading of cells and an approximately 500 µm diameter 
tip. 
In funnel type wells, cells do not need to be moved to 
designated areas. Instead, cells loaded in the funnel remain 
to stationary. The medium or chemical composition in the fun-
nel can be gradually changed to mimic conditions cells expe-
rience in vivo. In addition, the dimensions of the channels 
connected to the funnel can be controlled through soft-lithog- 
15 raphy processes such that cells are confined to the funnel. 
Cells may then be subjected to diverse flow conditions. 
PDMS slabs may be prepared by casting prepolymer (Syl-
gard 184, Dow-Corning) at a 1:10 curing agent-to-base ratio 
against positive relief features approximately 30 µm in height 
20 and 400 µm in width. The relief features may comprise SU-8 
(MicroChem, Newton, Mass.) and be fabricated on a thin 
glass wafer, approximately 200 µm thick, using backside 
diffused-light photolithography. 
Embodiments of the invention may include a tapered well 
25 which at its tip has an opening which communicates with one 
or a plurality of microchannels. The well and microchannels 
maybe filled with fluid. One or more cells, e.g., embryos, may 
be introduced into the well, for example, by pipet. The cells 
settle to the bottom, but are prevented from exiting the well 
3o due to them being larger than the microchannels. 
Fluid may be introduced into the well continuously or 
discontinuously. The fluid may contain the necessary growth 
media for the cells. In a well with a single hole at the bottom, 
for example, fluid may be caused to rise in the well from the 
35 microchannels, introducing extra nutrients, and then to fall, 
removing fluid which now contains exogenous substances, 
e.g., waste, via the microchannels. 
Introduction and removal of fluid can be made using con-
ventional gravity pumps or constant flow gravity driven 
40 pumps. Introduction and removal of fluid can also be made by 
outside supplies, such as pumps, or by on-board or "semi-on-
board" tactile actuator-based pumping systems. 
Wells may have inlets at other locations and or heights 
rather than at the bottom, so long as the entrance ways are 
45 sized such that cells will not pass into the channels. For 
example, there may be an opening at the bottom of a well and 
an opening near the middle or top, with fluid being supplied at 
the bottom and being removed closer to the top. 
Wells may have a polygonal shape whose walls are 
50 inclined, in either a linear or curved fashion, such that cells 
added to the well have a tendency to gravitate toward the 
bottom and center of the well. 
The material in which a well is formed may be, for 
example, thermosetting resin, thermoplastic, metal, glass, or 
55 ceramic. 
Embodiments of the invention may take the form of a 
multilayer device. The top layer containing a well, and con-
structed of a relatively rigid material so as to provide support 
for elastomeric layers or layers of lesser strength or modulus 
6o below. The top layer may comprise a hard transparent mate-
rial, such as glass or polymethylmethacrylate. The well may 
have a low surface roughness ranging, for example, between 
5 µm Ra and 0.1 µm Ra. 
The well may penetrate through the top layer, thus having 
65 an open, wide-mouthed end on one side of the top layer, and 
on the bottom layer, a relatively narrow hole which allows 
fluid communication with microchannels in the second layer. 
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The microchannels may be positioned closely with respect 
to the opening in the well to minimize misalignment. For 
example, misalignment should not exceed 50µm. The second 
layer may also constitute the bottom layer, particularly when 
the microchannels are substantially ontop of the second layer, 5 
e.g, abutting the bottom surface of the top layer. 
Embodiments of the invention may include microchannels 
that are, at least in part, along the bottom of the second layer. 
A third, or sealing layer may be applied thereto. This sealing 
layer may be rather thin, such that braille-type tactile actua- 10 
tors may act as valves and pumps for the various microchan-
nels. By this means, for example, fluid can be caused to flow 
or to be pumped in one or both directions in a given micro-
channel depending upon the valving, whether the valves are 
on or off, and whether a pump is pumping one way or the other 15 
with respect to the microchannel. 
In use, a well is first filled with fluid, e.g., an embryo culture 
medium, and one or more embryos added to the well. An oil 
overlay, produced by dropping one or two fine drops of oil 
onto the liquid surface in the well, is then provided. 20 
The oil prevents evaporation of liquid from the well, thus 
stabilizing the osmolality, or concentration, of the ingredients 
therein. The oil overlay also affects the flow of air, including 
specifically oxygen and CO2 into the fluid, and the release of 
these gases from the fluid. The oil may be any compatible oil, 25 
for example, a silicone oil, a paraffin oil, or a polyethylene 
oligomer oil. For the same reason, the second or third layers, 
if present, may include, for example, parylene, or other mate-
rials, which minimize water loss. 
The second and third layers may be made of cast elastomer, 30 
particularly when the embodiments employ tactile actuators. 
If "off-chip" fluid supply or valving is used, however, the use 
of an elastomer is not necessary, and other materials, such as 
cast epoxy, injection molded thermoplastic, or glass, can be 
used. The surface of these materials should be bio-compat- 35 
ible, and if not, should be coated appropriately. 
Zygotes may be introduced into a well containing a fluid as 
is conventionally employed for embryo culture. The fluid in 
the well is then covered with oil and incubated at a suitable 
temperature. Fluid is directed into and out of the well through 40 
microchannels continuously or discontinuously, e.g., a back 
and forth type of fluid supply wherein the fluid level in the 
well increases and then decreases cyclically. The growing 
embryo may be inspected by conventional optical micros-
copy methods, and when judged grown to the proper stage, 45 
the embryo is removed from the well. If the top of the well is 
larger then the bottom, one-step removal is particularly easy 
and the risk of damage to the embryo is low. 
Embodiments of the invention may contain microchannels 
whose flow characteristics are to be actively varied and 50 
formed in a compressible or distortable elastomeric material 
such as an organopolysiloxane elastomer. Substrates, how-
ever, may be constructed of hard, e.g., substantially non-
elastic material at portions where active control is not desired. 
Embodiments of the invention may contain at least one 55 
active portion which alters the shape or volume of chambers 
or passageways ("empty space"). Such active portions 
include mixing portions, pumping portions, valving portions, 
flow portions, channel or reservoir selection portions, cell 
crushing portions, and unclogging portions. These active por- 60 
tions induce some change in the fluid flow, fluid characteris-
tics, channel, or reservoir characteristics by exerting a pres-
sure on the relevant portions of the microfluidic device, and 
thus alter the shape or volume of the empty space which 
constitutes these features. The term "empty space" refers to 65 
the absence of substrate material. In use, the empty space may 
be filled with fluid. 
The active portions may be activatable by pressure to close 
their respective channels or to restrict the cross-sectional area 
of the channels to accomplish the desired active control. To 
achieve this purpose, the channels or reservoirs may be con-
structed in such a way that modest pressure from the exterior 
of the microfluidic device causes the channels or reservoirs 
("microfluidic features") to compress, causing local restric-
tion or total closure of the respective feature. 
Walls surrounding the feature and external surfaces may be 
elastomeric such that a minor amount of pressure causes an 
external surface and, optionally, the internal feature walls to 
distort, either reducing cross-sectional area at this point or 
completely closing the feature. 
The pressure required to "activate" the active portions) of 
the device may be supplied by an external tactile device such 
as a refreshable Braille display. The tactile actuator contacts 
the active portion of the device, and when energized, extends 
and presses upon the deformable elastomer, restricting or 
closing the feature in the active portion. 
Dimensions of the various flow channels and reservoirs 
may be determinedby volume and flow rate properties. Chan-
nels which are designed for complete closure may be of a 
depth such that the elastomeric layer between the microchan-
nel and the actuator can approach the bottom of the channel. 
Manufacturing the substrate of elastomeric material facili-
tates complete closure, in general, as does also a cross-section 
which is rounded, particularly at the furthest corners (further 
from the actuator). The depth will also depend, for example, 
on the extension possible for the actuator's extendable pro-
trusions, e.g., pins. Thus, channel depths may vary, for 
example, from I nm to 500 µm. 
Embodiments of the invention may be prepared through 
the use of a negative photoresist, for example, SU-8 50 pho-
toresist (Micro Chem. Corp., Newton, Mass.) The photoresist 
may be applied to a glass substrate and exposed from the 
uncoated side through a suitable mask. Since the depth of cure 
is dependant on factors such as length of exposure and inten-
sity of the light source, features ranging from very thin up to 
the depth of the photoresist may be created. The unexposed 
resist is removed, leaving a raised pattern on the glass sub-
strate. The curable elastomer is cast onto this master and then 
removed. 
The material properties of SU-8 photoresist and the diffuse 
light from an inexpensive light source can be employed to 
generate microstructures and channels with cross-sectional 
profiles that are rounded and smooth at the edges yet flat at the 
top, e.g, bell-shaped. Short exposures tend to produce a radi-
used top, while longer exposures tend to produce a flat top 
with rounded corners. Longer exposures also tend to produce 
wider channels. These profiles are ideal for use as compres-
sive, deformation-based valves that require complete col-
lapse of the channel structure to stop fluid flow. With such 
channels, Braille-type actuators produce full closure of the 
microchannels, thus producing a very useful valved micro-
channel. Such shapes also lend themselves to produce uni-
form flow fields, and have good optical properties as well. 
In a typical procedure, a photoresist layer is exposed from 
the backside of the substrate through a mask, for example 
photoplotted film, by diffused light generated with an ultra-
violet (UV) transilluminator. Bell-shaped cross-sections are 
generated due to the way in which the spherical wavefront 
created by diffused light penetrates into the negative photo-
resist. The exposure dose dependent change in the SU-8 
absorption coefficient limits exposure depth at the edges. 
The exact cross-sectional shapes and widths of the fabri-
cated structures may be determined by a combination of 
photomask feature size, exposure time/intensity, resist thick- 
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ness, and distance between the photomask and photoresist. 
Although backside exposure makes features which are wider 
than the size defined by the photomask and in some cases 
smaller in height compared to the thickness of the original 
photoresist coating, the change in dimensions of the trans- 5 
ferred patterns is readily predicted from mask dimensions and 
exposure time. 
The relationship between the width of the photomask pat-
terns and the photoresist patterns obtained is essentially lin-
ear, e.g., slope of 1, beyond a certain photomask aperture size. i0 
This linear relationship allows straightforward compensation 
of the aperture size on the photomask through simple sub-
traction of a constant value. When exposure time is held 
constant, there is a threshold aperture size below which 15 
incomplete exposure will cause the microchannel height to be 
lower than the original photoresist thickness. Lower exposure 
doses will make channels with smoother and more rounded 
cross-sectional profiles. Light exposure doses that are too 
slow or photoresist thicknesses that are too large, however, 20 
are insufficient in penetrating through the photoresist, result-
ing in cross-sections that are thinner than the thickness of the 
original photoresist. 
The suitability of bell-shaped cross-section microchannels 
of 30 µm thickness may be evaluated by exerting an external 25 
force onto the channel using a piezoelectric vertical actuator 
of commercially available refreshable Braille display. Spaces 
may be left between the membrane and the wall when the 
channel cross-section has discontinuous tangents, such as in 
rectangular cross-sections. In contrast, a channel with a bell - 30 
shaped cross-section may be fully closed under the same 
conditions. When a Braille pin is pushed against a bell-shaped 
or rectangular-shaped cross-section microchannel through a 
200 µm PDMS membrane, the bell-shaped channels may be 
fully closed while the rectangular channels of the same width 35 
may have considerable leakage. 
When used as deformation-based microfluidic valves, bell-
shaped microchannels may show self-sealing upon compres-
sion compared to conventional rectangular or semi-circular 
cross-section channels. By way of example, a bell-shaped 40 
channel, having a width and height of 30 µm, may be com-
pletely closed by an IS gf-force squeeze of a Braille pin. 
Channels that have the bell-shaped cross-sections with 
gently sloping sidewalls may not be fabricated by melting 
resist technology, one of the most convenient methods to 45 
fabricate photomask-definable rounded patterns, because the 
profile is determined by surface tension. 
Bell-shaped channels maximize the cross-sectional area 
within microfluidic channels without compromising the abil-
ity to completely close channels upon deformation. Further- 50 
more, bell-shaped cross-sections provide channels with flat 
ceilings and floors, which is advantageous for reducing aber-
rations in optical microscopy and in obtaining flow fields with 
a more uniform velocity profile across the widths of the 
channel. These advantages of microchannels with bell- 55 
shaped cross-sectional shapes combined with the convenient, 
inexpensive, and commercially available valve actuation 
mechanism based on refreshable Braille displays will be use-
ful for a wide range of microfluidic applications such as 
microfluidic cell culture and analysis systems, biosensors, 60 
and on-chip optical devices such as microlenses. 
The extension outwards of tactile actuators should be suf-
ficient for their desired purpose. Complete closure of a 40 µm 
deep microchannel, for example, will generally require a 40 
µm extension, e.g., pin, or more when a single actuator is 65 
used, and about 20 µm or more when dual actuators on oppo-
site sides of the channel are used.  
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For peristaltic pumping, mixing, and flow regulation, 
lesser extensions relative to channel height are useful. The 
areal size of the tactile activators may vary appropriately with 
channel width and function, and may range from 40 µm to 
about 2 mm. Larger and smaller sizes are possible as well. 
Appendix A discloses a handheld recirculation system and 
customized media for microfluidic cell culture. Appendix B 
discloses a device for embryo culture and use thereof. Appen-
dix C discloses integrated microfluidic control employing 
programable tactile actuators. Appendix D discloses a com-
puterized control method and system for microfluidics and 
computer program product for use therein. Embodiments of 
the invention may take the form of embodiments, or portions 
of embodiments, described in Appendices A, B, C, and D. 
Appendix A 
Many modifications of the present invention will be appar-
ent to those skilled in the art, and are part of the subject matter 
disclosed herein. The clamping mechanism, for example, 
may be replaced or augmented by other clamping mecha-
nisms, including simple clamps which are separate from but 
engageable with the fingerplate, or which can span the height 
of the entire device, including the braille display module. 
In similar manner, while the transparent heating element is 
described as being fabricated on a glass slide, it will be 
appreciated that this glass slide may be incorporated into a 
disposable device, become an integrated part thereof rather 
than a separate device. While less favorable, the heating ele-
ment may also be disposed directly on the microfluidics chip. 
The heating unit may also be patterned such that only portions 
of the glass slide or chip are heated, thus conserving electrical 
power as well as avoiding heat in areas where heating is not 
desired, for example in fluid storage areas. 
In advanced versions of the present lab-on-chip, it is desir-
able to have a battery power supply, either one-time use or 
rechargeable, on the chip itself, together with electrical cir-
cuitry for controlled operation of the heater unit, and of the 
tactile actuators also, when this is desired. The ability to 
divorce the structure from corded power supplies allows the 
module to be easily transported to other stations for testing, 
analysis, etc., while preserving the microenvironment within 
the module. 
The subject invention further pertains to PMDS or other 
elastomeric silicone structures which incorporate a film, coat-
ing, or membrane over all or only a portion of the module 
structure, which serves as a vapor barrier to minimize evapo-
ration of liquids contained in the channels, reservoirs, etc., of 
the devices. Suitable vapor barriers are, in general, relatively 
pore free, hydrophobic films, e.g. of parylene. In addition, 
films which are resistant to the flow of oxygen, of carbon 
dioxide, or both these gases may also be applied to minimize 
any influence of the ambient atmosphere on the conditions 
established within the device. Such films are well known from 
the field of plastic, particularly polyethylene terephthalate, 
drink containers. 
Appendix B 
It has now been surprisingly discovered that embryos may 
be grown with good survival rates in an efficient manner by 
growth at the bottom of a well which is in communication 
with a microchannel device supplying fluid to the well proxi-
mate its bottom. The bottom opening is sized so as not to 
allow the embryo to enter the channel. 
The invention may be described with relation to the accom-
panying drawings, many of which illustrate the volumes or 
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hollows, channels, etc. within the microfluidics device rather 
than the walls of the device themselves. As illustrated, the best 
mode of the device is a generally conical well which at its tip 
has an opening which communicates with one or a plurality of 
microchannels. The well is filled with fluid, as are the micro-
channels, and one or more embryos are introduced into the 
well, for example by pipet. The embryos settle to the bottom, 
but are prevented from exiting the well due to them being 
larger than the holes in the well. 
Fluid may be introduced into the well continuously or 
discontinuously, the fluid preferably containing the necessary 
growth media for the embryo. For example, in a well with a 
single hole at the bottom, fluid may be caused to rise in the 
well from the microchannels, introducing extra nutrients, and 
then to fall, removing fluid which now contains exogenous 
substances (waste) via the microchannels. 
Introduction and removal of fluid can be made using con-
ventional gravity pumps, or constant flow gravity driven 
pumps. Fluid can also be supplied by outside supplies such as 
pumps, etc., or preferably by on-board or "semi-on board" 
tactile actuator-based pumping systems. 
The well can also have inlets at other locations and or 
heights rather than exclusively at the bottom, so long as the 
entrance ways to the channels are sized such that the embryos 
will not pass into the channels. For example, there might be an 
opening at the bottom of the well and an opening near the 
middle or top, with fluid being supplied at the bottom, for 
example, and being removed closer to the top. 
The well also need not be entirely conical in shape, but is 
preferably shaped such that the walls are inclined, regardless 
of whether linear or curved such that the embryo's will have 
a natural tendency to gravitate toward the bottom and center 
of the well. The material of the well is not overly critical, and 
may be thermosetting resin or thermoplastic, metal, glass, 
ceramic, etc. In preferred constructions, the device is a mul-
tilayer device, the top layer containing the well, and con-
structed of relatively rigid material so as to provide support 
for elastomeric layers or layers of lesser strength and/or 
modulus below. 
Thus, it is preferable that the top layer be of hard transpar-
ent material such as glass, polymethylmethacrylate, etc. The 
conical well should have a low surface roughness, preferably 
below 5 µm Ra, more preferably less than 1 µm Ra, and yet 
more preferably less than 0.1 µm Ra. 
In preferred devices, the conical well penetrates entirely 
through the top layer, thus having an open, wide-mouthed end 
on one side of the top layer, and on the bottom this layer, a 
relatively narrow hole which allows fluid communication 
with the microchannels in the second layer. The second layer 
preferably directly abuts the first layer, and has one or a 
plurality of microchannels which are in fluid communication 
with the conical well. It is relatively important that the chan-
nels be positioned closely with respect to the opening in the 
well. For example misalignment should preferably be maxi-
mized at 50 µm. The second layer may also constitute the 
bottom layer, particularly when the microfluid channels are 
substantially on top of the second layer, i.e. abutting the 
bottom surface of the top layer. However, in preferred 
devices, the channels are at least in part along the bottom of 
the second layer and a third, or sealing layer is applied thereto. 
This sealing layer is preferably rather thin, such that braille-
type tactile actuators may act as valves and pumps for the 
various microchannels. By this means, for example, fluid can 
be caused to flow or to be pumped in only one direction in a 
given microchannel, or can be bidirectional flow, depending 
14 
upon the valving, whether the valves are on or off, and 
whether a pump is pumping one way or the other with respect 
to the channel. 
In use, the device is first filled with fluid, for example an 
5 embryo culture medium, and one or more embryos added to 
the well, An oil overlay, produced by dropping one or two fine 
drops of oil onto the liquid surface in the well is then pro-
vided. The oil prevents evaporation of liquid from the well, 
thus changing the osmolality, or concentration, of the ingre- 
10 dients therein. It also affects the flow of air, including specifi-
cally oxygen and CO z into the fluid, and the release of these 
gases from the fluid. The oil may be any compatible oil, for 
example a silicone oil, a paraffin oil, a polyethylene oligomer 
oil, etc. For the same reason, portions of the apparatus in the 
15 second and/or third layers may be coated, for example with 
parylene or other coating which minimizes, particularly, 
water loss. 
The second and third layers are preferably made of cast 
elastomer, particularly when the valving and pumping 
20 embodiments employing tactile actuators are employed. 
However, if "off-chip" fluid supply, valving, etc. is used, then 
use of an elastomer is not necessary, and other materials such 
as cast epoxy, injection molded thermoplastic, glass, etc., can 
be used. It is of course recognized that the surface of these 
25 materials should be compatible with embryo culture, and if 
not, should be coated appropriately. 
The process of the subject invention requires introduction 
of zygote(s) into the well which contains fluid, preferably a 
growth fluid as is conventionally employed for embryo cul- 
30 ture. The fluid in the conical well is then covered with oil, 
preferably mineral oil, and the device incubated at a suitable 
temperature. Fluid is directed into and out of the well through 
the microchannels continuously or discontinuously. For 
example, a back and forth type of fluid supply wherein the 
35 fluid level in the well increases and then decreases cyclically 
has been found most advantageous. The growing embryo may 
be inspected by conventional optical microscopy methods, 
and when judged grown to the proper stage, the embryo is 
removed from the well. Because the top of the well is larger 
40 then the bottom, removal is particularly easy and the risk of 
damage is low. 
Appendix C 
45 	 The microfluidic devices of the present invention contain 
microchannels whose flow characteristics are to be actively 
varied, formed in a compressible or distortable elastomeric 
material. Thus, it is preferred that substantially the entire 
microfluidic device be constructed of a flexible elastomeric 
50 material such as an organopolysiloxane elastomer 
("PDMS"), as described hereinafter. However, the device 
substrate may also be constructed of hard, i.e., substantially 
non-elastic material at portions where active control is not 
desired, although such construction generally involves added 
55 construction complexity and expense. The generally planar 
devices preferably contain a rigid support of glass, silica, 
rigid plastic, metal, etc. on one side of the device to provide 
adequate support, although in some devices, actuation from 
bothmajor surfaces may require that these supports be absent, 
60 or be positioned remote to the elastomeric device itself. 
The microfluidic devices of the present invention contain at 
least one active portion which alters the shape and/or volume 
of chambers or passageways ("empty space"), particularly 
fluid flow capabilities of the device. Such active portions 
65 include, without limitation, mixing portions, pumping por-
tions, valving portions, flow portions, channel or reservoir 
selection portions, cell crushing portions, unclogging por- 
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tions, etc. These active portions all induce some change in the 	 Research, Inc. said to reduce the cost of Braille tactile cells 
fluid flow, fluid characteristics, channel or reservoir charac- 	 from 70 $ U.S. per cell to Ca. 5-10 $/cell. Piezoelectric 
teristics, etc. by exerting a pressure on the relevant portions of 	 actuators are also usable where a piezoelectric element 
the device, and thus altering the shape and/or volume of the 	 replaces the electrorheological fluid, and electrode position- 
empty space which constitutes these features. The term 5 ing is altered accordingly. 
"empty space" refers to the absence of substrate material. In 	 The microfluidic devices of the present invention have 
use, the empty space is usually filled with fluids, microorgan- 	 many uses. In cell growth, the nutrients supplied may need to 
isms, etc. 	 be varied to simulate availability in living systems. By pro- 
The active portions of the device are activatable by pressure 	 viding several supply channels with active portions to close or 
to close their respective channels or to restrict the cross- io restrict the various channels, supply of nutrients and other 
sectional area of the channels to accomplish the desired active 	 fluids may be varied at will. An example is a three dimen- 
control. To achieve this purpose, the channels, reservoirs, etc. 	 sional scaffolding system to create bony tissue, the scaffold- 
are constructed in such a way that modest pressure from the 	 ing supplied by various nutrients from reservoirs, coupled 
exterior of the microfluidic device causes the channels, res- 	 with peristaltic pumping to simulate natural circulation. 
ervoirs, etc. ("microfluidic features") to compress, causing 15 	 A further application involves cell crushing. Cells may be 
local restriction or total closure of the respective feature. To 	 crushed by transporting them in channels through active por- 
accomplish this result, the walls within the plane of the device 	 tions and actuating channel closure to crush the cells flowing 
surrounding the feature are preferably elastomeric, and the 	 through the channels. Cell detection may be achieved, for 
external surfaces (e.g., in a planar device, an outside major 	 example, by flow cytometry techniques using transparent 
surface) are necessarily elastomeric, such that a minor 20 microfluidic devices and suitable detectors. Embedding opti- 
amount of pressure causes the external surface and optionally 	 cal fibers at various angles to the channel can facilitate detec- 
the internal feature walls to distort, either reducing cross- 	 tion and activation of the appropriate activators. Similar 
sectional area at this point or completely closing the feature. 	 detection techniques, coupled with the use of valves to vary 
The pressure required to "activate" the active portions) of 	 the delivery from a channel to respective different collection 
the device is supplied by an external tactile device such as are 25 sites or reservoirs can be used to sort embryos and microor- 
used in refreshable Braille displays. The tactile actuator con- 	 ganisms, including bacteria, fungi, algae, yeast, viruses, 
tacts the active portion of the device, and when energized, 	 sperm cells, etc. 
extends and presses upon the deformable elastomer, restrict- 	 Growth of embryos generally require a channel or growth 
ing or closing the feature in the active portion. 	 chamber which is capable of accommodating the embryo and 
Rather than close or restrict a feature by being energized, 3o allowing for its subsequent growth. Such deep channels can- 
the tactile actuator may be manufactured in an extended posi- 	 not effectively be closed, however. A microfluidics device 
tion, which retracts upon energizing, or may be applied to the 	 capable of embryo growth may be fabricated by multiexpo- 
microfluidics device in an energized state, closing or restrict- 	 sure photolithography, using two masks. First, a large, some- 
ing the passage, further opening the passage upon de-ener- 	 what rectangular (200 .mu.m width.times.200 .mu.m depth) 
gizing. 	 35 channel, optionally with a larger 200 .mu.m deep by 300 
The preferred actuators at the present time are program- 	 .mu.m length and 300 .mu.m width growth chamber at one 
mable Braille display devices such as those previously com- 	 end is fabricated. Merging with the 200 .mu.m.times.200 
mercially available from Telesensory as the Navigator.TM. 	 .mu.m channel is a smaller channel with a depth of ca. 30 
Braille Display with Gateway.TM. software which directly 	 .mu.m, easily capable of closure by a Braille pin. Exiting the 
translates screen text into Braille code. These devices gener-  4o bulbous growth chamber are one or more thin (30 .mu.m) 
ally consist of a linear array of "8-dot' cells, each cell and 	 channels. In operation, embryo and media are introduced into 
each cell "dot' of which is individually programmable. Such 	 the large channel and travel to the bulbous growth chamber. 
devices are used by the visually impaired to convert a row of 
	
Because the exit channels from the growth chamber are very 
text to Braille symbols, one row at a time, for example to 	 small, the embryo is trapped in the chamber. The merging 
"read" a textual message, book, etc. These devices are pres-  45 channels and exit channels can be used to supply nutrients, 
ently preferred because of their ready commercial availabil- 	 etc., in any manner, i.e. continuous, pulsating, reverse flow, 
ity. The microfluidic device active portions are designed such 	 etc. The embryo may be studied by spectroscopic and/or 
that they will be positionable below respective actutable 	 microscopic methods, and may be removed by separating the 
"dots" or protrusions on the Braille display. Braille displays 	 elastomeric layer covering the PDMS body which houses the 
are available from Handy Tech, Blazie, and Alva, among 50 various channels. 
other suppliers. 	 Construction of fluidic devices is preferably performed by 
However, to increase flexibility, it is possible to provide a 	 soft lithography techniques, as described, for example by D. 
regular rectangular array usable with a plurality of microflu- 	 C. Duffy et al., Rapid Prototyping of Microfluidic Systems in 
idics devices, for example having a l0.times.10, 16.times.16, 	 Poly(dimethylsiloxane), ANALYTICAL CHEMISTRY 70, 
20.times.100, 100.times.100, or other array. The more close 55 4974-4984(1998). See also, 7.R. Anderson etal.,ANALYTI- 
the spacing and the higher the number of programmable 	 CAL CHEMISTRY 72, 3158-64 (2000); and M. A. Unger et 
extendable protrusions, the greater is the flexibility in design 	 al., SCIENCE 288,113-16 (2000). Addition-curable RTV-2 
of microdevices. Production of such devices follows the 	 silicone elastomers such as SYLGARD.RTM. 184, Dow 
methods of construction known in the art. Addressability also 	 Corning Co., can be used for this purpose. 
follows from customary methods. Non-regular arrays, i.e. in 60 	 The dimensions of the various flow channels, reservoirs, 
patterns having actuators only where desired are also pos- 	 growth chambers, etc. are easily determined by volume and 
sible. 	 flow rate properties, etc. Channels which are designed for 
Suitable Braille display devices suitable for non-integral 	 complete closure must be of a depth such that the elastomeric 
use are available from Handy Tech Electronik GmbH, Horb, 	 layer between the microchannel and the actuator can 
Germany, as the Graphic Window Professional.TM. (GWP), 65 approach the bottom of the channel. Manufacturing the sub- 
having an array of 24.times.16 tactile pins. Pneumatic dis- 	 strate of elastomeric material facilitates complete closure, in 
plays operated by microvalves have been disclosed by Orbital 	 general, as does also a cross-section which is rounded, par- 
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ticularly at the furthest corners (further from the actuator). 	 exposure time. The relationship between the width of the 
The depth will also depend, for example, on the extension 	 photomask patterns and the photoresist patterns obtained is 
possible for the actuator's extendable protrusions. Thus, 	 essentially linear (slope of 1) beyond a certain photomask 
channel depths may vary quite a bit. A depth of less than 100 	 aperture size. This linear relationship allows straightforward 
.mu.m is preferred, more preferably less than 50 .mu.m. 5 compensation of the aperture size on the photomask through 
Channel depths in the range of 10 .mu.m to 40 .mu.m are 	 simple subtraction of a constant value. When exposure time is 
preferred for the majority of applications, but even very low 	 held constant, there is a threshold aperture size below which 
channel depths, i.e. 1 nm are feasible, and depths of 500 
	
incomplete exposure will cause the microchannel height to be 
.mu.m are possible with suitable actuators, particularly if 
	
lower than the original photoresist thickness. Lower exposure 
partial closure ("partial valving") is sufficient. 	 io doses will make channels with smoother and more rounded 
The substrate may be of one layer or a plurality of layers. 	 cross-sectional profiles. Light exposure doses that are too 
The individual layers may be prepared by numerous tech- 	 slow (or photoresist thicknesses that are too large), however, 
niques, including laser ablation, plasma etching, wet chemi- 	 are insufficient in penetrating through the photoresist, result- 
cal methods, injection molding, press molding, etc. However, 	 ing in cross-sections that are thinner than the thickness of the 
as indicated previously, casting from curable silicone is most 15 original photoresist. 
preferred, particularly when optical properties are important. 	 The suitability of bell-shaped cross-section microchannels 
Generation of the negative mold can be made by numerous 	 of 30 .mu.m thickness to be used as deformation-based valves 
methods, all of which are well known to those skilled in the 	 was evaluated by exerting an external force onto the channel 
art. The silicone is then poured onto the mold, degassed if 	 using a piezoelectric vertical actuator of commercially avail- 
necessary, and allowed to cure. Adherence of multiple layers 2o able refreshable Braille displays. Spaces may be left between 
to each other may be accomplished by conventional tech- 	 the membrane and the wall when the channel cross-section 
niques. 	 has discontinuous tangents, such as in rectangular cross-sec- 
A preferred method of manufacture of some devices 	 tions. In contrast, a channel with a bell-shaped cross-section 
employs preparing a master through use of a negative photo- 	 is fully closed under the same conditions. When a Braille pin 
resist. SU-S 50 photoresist from Micro Chem. Corp., Newton, 25 is pushed against a bell-shaped or rectangular-shaped cross- 
Mass., is preferred. The photoresist may be applied to a glass 	 section microchannel through a 200 .mu.m poly(dimethylsi- 
substrate and exposed from the uncoated side through a suit- 	 loxane) (PDMS) membrane, the bell-shaped channels were 
able mask. Since the depth of cure is dependant on factors 	 fully closed while the rectangular channels of the same width 
such as length of exposure and intensity of the light source, 	 had considerable leakage. 
features ranging from very thin up to the depth of the photo- 30 	 The technique described is cost- and time-effective com- 
resist may be created. The unexposed resist is removed, leav- 	 pared to other photolithographic methods for generating well 
ing a raised pattern on the glass substrate. The curable elas- 	 defined rounded profiles such as gray-scale mask lithography, 
tomer is cast onto this master and then removed. 	 or laser beam polymerization because there is no need for 
The material properties of SU-S photoresist and the diffuse 	 special equipment such as lasers, collimated light sources 
light from an inexpensive light source can be employed to 35 (mask aligner), or submicron resolution photomasks; it only 
generate microstructures and channels with cross-sectional 	 requires a transilluminator available in many biological labs. 
profiles that are "rounded and smooth" at the edges yet flat at 	 In addition, the backside exposure technique can generate 
the top (i.e. bell-shaped). Short exposures tend to produce a 	 more profiles compared to other soft lithography-based pat- 
radiused top, while longer exposures tend to produce a flat top 	 terning methods such as microfluidic mask lithography and 
with rounded corners. Longer exposures also tend to produce 40 the use of patterned laminar flows of etchant in an existing 
wider channels. These profiles are ideal for use as compres- 	 microchannel. 
sive, deformation-based valves that require complete col- 	 When used as deformation-based microfluidic valves, 
lapse of the channel structure to stop fluid flow, as disclosed 	 these bell-shaped microchannels showed improved self-seal- 
by M. A. Unger, et al., SCIENCE 2000, 288, 113. With such 
	
ing upon compression compared to conventional rectangular 
channels, Braille-type actuators produced full closure of the 45 or semi-circular cross-section channels as demonstrated by 
microchannels, thus producing a very useful valved micro- 	 simulations, and by experiments. A bell-shaped channel 
channel. Such shapes also lend themselves to produce uni- 	 (width: 30 .mu.m; height 30.mu.m) was completely closed by 
form flow fields, and have good optical properties as well. 	 an 18 gf-force squeeze of a Braille pin. It is notable that 
In a typical procedure, a photoresist layer is exposed from 	 channels that have the bell-shaped cross-sections with "gen- 
the backside of the substrate through a mask, for example 50 tly sloping" sidewalls cannot be fabricated by melting resist 
photoplotted film, by diffused light generated with an ultra- 	 technology, one of the most convenient methods to fabricate 
violet (UV) transilluminator. Bell-shaped cross-sections are 	 photomask-definable rounded patterns, because the profile is 
generated due to the way in which the spherical wavefront 	 determined by surface tension. The bell-shaped channels 
created by diffused light penetrates into the negative photo- 	 maximize the cross-sectional area within microfluidic chan- 
resist. The exposure dose dependent change in the SU-S 55 nels without compromising the ability to completely close 
absorption coefficient (3985 m.sup.-1 unexposed to 9700 	 channels upon deformation. For example, the channel cross- 
m.sup.-1 exposed at 365 mu) limits exposure depth at the 	 section described here is larger than previously reported, 
edges. 	 pneumatically actuated deformation-based valves (100 
The exact cross-sectional shapes and widths of the fabri- 	 .mu.m in width; 201 m in height) and may be more suitable 
cated structures are determined by a combination of photo- 60 for mammalian cell culture. Furthermore, the bell-shaped 
mask feature size, exposure time/intensity, resist thickness, 	 cross-sections provide channels with flat ceilings and floors, 
and distance between the photomask and photoresist. 	 which is advantageous for reducing aberrations in optical 
Although backside exposure makes features which are wider 	 microscopy and in obtaining flow fields with a more uniform 
than the size defined by the photomask and in some cases 	 velocity profile across the widths of the channel. These 
smaller in height compared to the thickness of the original 65 advantages of microchannels with bell-shaped cross-sec- 
photoresist coating, the change in dimensions of the trans- 	 tional shapes combinedwith the convenient, inexpensive, and 
ferred patterns is readily predicted from mask dimensions and 	 commercially available valve actuation mechanism based on 
US 8,865,464 B2 
19 
	
20 
refreshable Braille displays will be useful for a wide range of 	 vided to the living organism. The microfluidic device may 
microfluidic applications such as microfluidic cell culture and 	 provide laminar, pseudo-multiple laminar or non-laminar 
analysis systems, biosensors, and on-chip optical devices 	 flows. The microfluidic device may perform physical opera- 
such as microlenses. 	 tions on the living organism. The microfluidic device may be 
The extension outwards of the tactile actuators must be 5 used, for example, for general cell culture including cell 
sufficient for their desired purpose. Complete closure of a 40 	 washing and detachment, cell seeding and culture. The 
.mu.m deep microchannel, for example, will generally 	 microfluidic device may be used as a microreactor, a tissue 
require a 40 .mu.m extension ("protrusion") or more when a 	 culture device, a cell culture device, a cell sorting device, a 
single actuator is used, and about 20 .mu.m or more when 	 cell crushing device, a micro flow cytometer, a motile sperm 
dual actuators on opposite sides of the channel are used. For io sorter, a micro carburetor, a micro spectrophotometer, or a 
peristaltic pumping, mixing, and flow regulation, lesser 	 microscale tissue engineering device. The microfluidic 
extensions relative to channel height are useful. The areal size 	 device may includes sensors to determine states or flow char- 
of the tactile activators may vary appropriately with channel 	 acteristics of elements of the microfluidic device or the pas- 
width and function (closure, flow regulation, pumping, etc.), 	 sage of particles in a channel. The sensors may be, for 
and may preferably range from 40 .mu.m to about 2 mm, 15 example, optical, electrical, or electromechanical sensors. 
more preferably 0.5 mm to 1.5 mm. Larger and smaller sizes 	 In one embodiment, a microfluidic device includes micro- 
are possible as well. The actuators must generate sufficient 	 channels having flow characteristics that are actively varied 
force. The force generated by one Braille-type display pin is 	 and formed in a compressible or distortable elastomeric mate- 
approximately 176 mN, and in other displays may be higher 	 rial. In one embodiment, the entire microfluidic device is 
or lower. 	 20 constructed of a flexible elastomeric material, such as an 
By use of the present invention, numerous functions can be 	 organopolysiloxane elastomer ("PDMS"), as described here- 
implemented on a single device. Use of multiple reservoirs 	 inafter. However, the device substrate may also be con- 
for supply of nutrients, growth factors, etc. is possible. The 	 structed of hard, e.g., substantially non-elastic material at 
various reservoirs make possible any combination of fluid 	 portions, where active control is not desired. 
supply, i.e. from a single reservoir at a time, or from any 25 	 The microfluidic devices may contain at least one active 
combination of reservoirs. This is accomplished by establish- 	 portion that alters the shape and/or volume of chambers or 
ing fluid communication with a reservoir by means of a 	 passageways ("empty space"), particularly fluid flow capa- 
valved microchannel, as previously described. By program- 	 bilities of the device. Such active portions include, without 
ming the Braille display or actuator array, each individual 
	 limitation, mixing portions, pumping portions, valving por- 
reservoir may be connected with a growth channel or cham-  30 tions, flow portions, channel or reservoir selection portions, 
ber at will. By also incorporating a plurality of extendable 	 cell crushing portions, and unclogging portions. These active 
protrusions along a microchannel supply, peristaltic pumping 	 portions all induce some change in the fluid flow, fluid char- 
may be performed at a variety of flow rates. Uneven, pulsed 	 acteristics, channel or reservoir characteristics, by exerting a 
flow typical of vertebrate circulatory systems can easily be 	 pressure on the relevant portions of the device, and thus 
created. Despite the flexibility which the inventive system 35 altering the shape and/or volume of the empty space which 
offers, construction is straightforward. The simplicity of the 	 constitutes these features. The term "empty space" refers to 
microfluidics device per se, coupled with a simple, program- 	 the absence of substrate material. In use, the empty space is 
mable external actuator, enables a cost-effective system to be 	 usually filled with fluids or microorganisms. 
prepared, where the microfluidic device is relatively inexpen- 	 The active portions of the device are activatableby pressure 
sive and disposable, despite its technological capabilities. 	 40 to close their respective channels or to restrict the cross- 
Combinatorial, regulated flow with multiple pumps and 	 sectional area of the channels to accomplish the desired active 
valves that offer more flexibility in microfluidic cell studies in 	 control. To achieve this purpose, the channels, reservoirs, or 
a laptop to handheld-sized system are created by using a grid 	 other elements are constructed in such a way that modest 
of tiny actuators on refreshable Braille displays. These dis- 	 pressure from the exterior of the microfluidic device causes 
plays are typically used by the visually impaired as tactile 45 the channels, reservoirs or other elements ("microfluidic fea- 
analogs to computer monitors. Displays usually contain 	 tures") to compress, causing local restriction or total closure 
20-80 rows of cells, each holding 8 (4.times.2) vertically 	 of the respective feature. To accomplish this result, the walls 
moving pins (.about. 1- 1.3 mm). Two pins on the same cell 	 within the plane of the device surrounding the feature are 
may typically be 2.45 mm apart center to center and 3.8 mm 	 preferably elastomeric, and the external surfaces (e.g., in a 
apart on different cells. Each pin may have the potential to 50 planar device, an outside major surface) are elastomeric, such 
protrude 0.7.about.I mm upward using piezoelectric mecha- 	 that a minor amount of pressure causes the external surface 
nisms, and may hold up to. about. 15-20 cN. Control of Braille 	 and optionally the internal feature walls to distort, either 
pins actuators is accomplished by changing a line of text in a 	 reducing cross-sectional area at this point or completely clos- 
computer program. Unique combinations of Braille pins will 
	 ing the feature. 
protrude depending on the letters displayed at a given time. 55 	 The pressure used to "activate" the active portion(s) of the 
Braille displays are pre-packaged with software, easy to use, 	 device is supplied by an external tactile device, such as are 
and readily accessible. They are designed for individual use, 	 used in refreshable Braille displays of the actuator system. 
and range from walkman to laptop sizes while using AC or 	 The tactile actuator contacts the active portion of the device, 
battery power. By using the moving Braille pins against chan- 	 and when energized, extends and presses upon the deform- 
nels in elastomeric, transparent rubber, it is possible to 6o able elastomer, restricting or closing the feature in the active 
deform channels and create in situ pumps and valves. 	 portion. 
In some embodiments, rather than close or restrict a feature 
Appendix D 
	
by being energized, the tactile actuator may be manufactured 
in an extended position, which retracts upon energizing, or 
Embodiments of microfluidic devices may be suitable for 65 may be applied to the microfluidic device in an energized 
the culture of a living organism in a fluid. A microfluidic 	 state, closing or restricting the passage, further opening the 
device may control the flow and composition of fluids pro- 	 passage upon de-energizing. 
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A significant improvement in the performance, not only of 
the subject invention devices, but of other microfluidic 
devices which use pressure, e.g., pneumatic pressure, to acti-
vate device features, may be achieved by molding the device 
to include one or more voids adjacent the channel walls. 
These voids allow for more complete closure or distortion of 
the respective feature. 
In one embodiment, the actuator system is a programmable 
Braille display that includes a plurality of moveable pins that 
each engage a corresponding element of the microfluidic 
device to perform a fluidic operation. The elements of the 
microfluidic device include pumps and valves. The pins may 
be arranged in a regular geometric array. Such arrangement 
maybe used with different configurations of the microfluidic 
device. In this arrangement, some pins may not be used for 
particular microfluidic devices because no element in the 
device corresponds to the pin. Alternatively the pins may be 
selected to correspond to elements of a specific or a group of 
multifluidic devices. Each pin may be controlled indepen-
dently, and individually addressable. 
An example of an actuator system is a Telesensory system 
such as the NavigatorrM Braille Display with GatewayTM 
software, which directly translates screen text into Braille 
code. These devices generally comprise a linear array of 
"S-dot" cells, each cell and each cell "dot" of which is indi-
vidually programmable. Such devices are used by the visually 
impaired to convert a row of text to Braille symbols, one row 
at a time, for example to "read" a textual message or book. 
The microfluidic device active portions are designed suchthat 
they will be positionable below respective actuable "dots" or 
protrusions on the Braille display. Braille displays are avail-
able from Handy Tech, Blazie, and Alva, among other sup-
pliers. As will be describedbelow, the system may use various 
software programs for controlling the pins of the actuator 
system by allowing the user to select processes to be per-
formed on the organism, and then executing processes from a 
library. 
However, to increase flexibility, it is possible to provide a 
regular rectangular array usable with a plurality of microflu-
idic devices, for example having a 10x10, 16x16, 20x100, 
100x100 or other size array. The closer the spacing and the 
higher the number of programmable extendable protrusions, 
the greater is the flexibility in design of microdevices. Pro-
duction of such devices follows the methods of construction 
known in the art. Addressability also follows from customary 
methods. Non-regular arrays, e.g., in patterns having actua-
tors only where desired are also possible. 
Devices can also be constructed which integrate the tactile 
actuators with the microfluidic device. The actuators are still 
located external to the microfluidic device itself, but attached 
or bonded thereto to form an integrated whole. Other types of 
actuator systems may be used, such as a tactile actuator 
device, which employs a buildup of an electrorheological 
fluid, an electromechanical Braille-type device employing 
shape memory wires for displacement between "on" and 
"off' portions, devices employing electrorheologic or mag-
netorheologic working fluids or gels, a pneumatically oper-
ated Braille device, "voice coil" type structures, especially 
those employing strong permanent magnets, devices employ-
ing shape memory alloys and intrinsically conducting poly-
mer sheets. 
Suitable Braille display devices suitable for non-integral 
use are available from Handy Tech Electronik GmbH, Horb, 
Germany, as the Graphic Window ProfessionalTM (GWP), 
having an array of 24x16 tactile pins. Piezoelectric actuators 
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are also usable where a piezoelectric element replaces the 
electrorheological fluid, and electrode positioning is altered 
accordingly. 
The microfluidic device has many uses. The software 
5 describedherein automates the operationof these uses. In cell 
growth, the nutrients supplied may be varied to simulate 
availability in living systems. By providing several supply 
channels with active portions to close or restrict the various 
channels, supply of nutrients and other fluids may be varied at 
io will. An example is a three dimensional scaffolding system to 
create bony tissue, the scaffolding supplied by various nutri-
ents from reservoirs, coupled with peristaltic pumping to 
simulate natural circulation. 
Another application involves cell crushing. Cells may be 
15 crushed by transporting them in channels through active por-
tions and actuating channel closure to crush the cells flowing 
through the channels. Cell detection may be achieved, for 
example, by flow cytometry techniques using transparent 
microfluidic devices and suitable detectors. Embedding opti- 
20 cal fibers at various angles to the channel can facilitate detec-
tion and activation of the appropriate activators. Similar 
detection techniques, coupled with the use of valves to vary 
the delivery from a channel to respective different collection 
sites or reservoirs can be used to sort embryos and microor- 
25 ganisms, including bacteria, fungi, algae, yeast, viruses, and 
sperm cells. 
The software controls the actuator system to control the 
pressure and thus the opening and closing of the channel and 
the timing. Depending on the processes to be performed, the 
30 software may address the actuators individually or in groups, 
and in patterns to provide actions, such as a peristaltic pump-
ing action or a mixing action with respect to fluid in the 
channel. The software may monitor the sensors of the microf-
luidic device to selectively control the channel flow. 
35 As an illustrative example of peristaltic pump formed by 
three pins engaging the microfluidic device, a pattern, such as 
XXO, OXX, OOX, XOX in repetition, where X is a closed 
position and O is an open position, to pump fluid in a channel 
may be used. The resultant fluid flow is pulsatile, with tran- 
40 sient movements in both directions. The net movement can be 
predicted by its linear relationship to the pattern change fre-
quency, and flow direction can be switched by reversing the 
pattern of actuation. 
By use of the present invention, numerous functions can be 
45 implemented on a single device. Use of multiple reservoirs 
for supply of nutrients, growth factors, and the like is pos-
sible. The various reservoirs make possible any combination 
of fluid supply, e.g., from a single reservoir at a time, or from 
any combination of reservoirs. This is accomplished by estab- 
50 lishing fluid communication with a reservoir by means of a 
valved microchannel, as previously described. By program-
ming the actuator system, each individual reservoir may be 
connected with a growth channel or chamber at will. By also 
incorporating a plurality of extendable protrusions along a 
55 microchannel supply, peristaltic pumping may be performed 
at a variety of flow rates. Uneven, pulsed flow typical of 
vertebrate circulatory systems can easily be created. Combi-
natorial, regulated flow with multiple pumps and valves that 
offer more flexibility in microfluidic cell studies are created 
6o by using a grid of tiny actuators on refreshable Braille dis-
plays and executed automatically by software in response to 
user selections of processes to be performed. 
While embodiments of the invention have been illustrated 
and described, it is not intended that these embodiments 
65 illustrate and describe all possible forms of the invention. 
Rather, the words used in the specification are words of 
description rather than limitation, and it is understood that 
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various changes may be made without departing from the 
spirit and scope of the invention. 
What is claimed is: 
1. A method, comprising: 
a) providing a substrate comprising 
a reservoir formed in the substrate and having upper and 
lower portions, the upper portion being sized to per-
mit the insertion and removal of a cell mass from the 
reservoir; and 
a passage at least partially formed in the substrate and in 
fluid communication with the reservoir wherein a sur-
face of the passage comprises a deformable mem-
brane comprising a plurality of layers, wherein a first 
layer comprises a deformable elastomer and a second 
layer comprises a non-rigid polymer that blocks mois-
ture; 
b) inserting a cell mass in a reservoir of said substrate under 
conditions, wherein said lower portion of said reservoir 
has a width less than 250 micrometers to retain at least a 
portion of the cell mass within the lower portion of the 
reservoir, wherein said cell mass is prevented from 
entering said passage and the cell mass can be directly 
removed from the lower portion through the upper por-
tion; and 
c) culturing said cell mass in said reservoir such that said 
cell mass grows. 
2. The method of claim 1, wherein the cell mass is selected 
from the group consisting of a denuded human zygote, a 
denuded mammalian zygote, a clump of mammalian cells, 
and a single mammalian cell. 
3. The method of claim 1, wherein the passage adjacent the 
lower portion has a passage width and a passage height and 
wherein at least one of the passage height and the passage 
24 
width has a length selected from the group consisting of less 
than 500 micrometers, less than 250 micrometers, less than 
140 micrometers, less than 70 micrometers, less than 50 
micrometers, and less than 5 micrometers to retain at least a 
5 portion of the cell mass within the reservoir. 
4. The method of claim 1, wherein the lower portion of the 
reservoir has a width selected from the group consisting of 
less than 140 micrometers, less than 70 micrometers, less 
than 50 micrometers, and less than 5 micrometers. 
10 	 5. The method of claim 2, wherein said cell mass is a 
denuded human zygote. 
6. The method of claim 2, wherein said cell mass is a 
denuded mammalian zygote. 
15 	 7. The method of claim 1, wherein said reservoir and said 
passage comprise a fluid. 
8. The method of claim 7, further comprising the step of 
moving said fluid from said passage to said reservoir by 
deforming said deformable membrane. 
20 9. The method of claim 1, wherein said non-rigid polymer 
is parylene, polyvinylidene chloride or polyurethane. 
10. The method of claim 1, wherein said deformable elas-
tomer is PDMS. 
11. The method of claim 2, wherein said cell mass is a 
25 denuded human zygote and said lower portion of said reser-
voir has a width less than 140 micrometers. 
12. The method of claim 2, wherein said cell mass is a 
denuded mammalian zygote and said lower portion of said 
reservoir has a width less than 70 micrometers. 
30 	 13. The method of claim 2, wherein said cell mass is a 
single mammalian cells and said lower portion of said reser-
voir has a width less than 5 micrometers. 
